Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

Clinical trial NCT00467831 · TERMINATED

Trial details

NCT number: NCT00467831
Sponsor: National Human Genome Research Institute (NHGRI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hermansky-Pudlak Syndrome (HPS)Pulmonary Fibrosis Oculocutaneous Albinism Platelet Storage Pool Deficiency Metabolic Disease

Start date: 2007-04-01
Primary completion: 2012-11-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.